Telix Pharmaceuticals US
Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.
Based in IN
🤖
AI Overview
With $52K in lobbying spend across 3 quarterly filings, Telix Pharmaceuticals US is an active lobbying client. Their lobbying covers 3 issue areas.
$52K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $52K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, MED
- •Medicare reimbursement; working with Congress on legislation relating to the early detection and treatment of deadly diseases.
- •Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.